Magnetic resonance imaging (MRI) is very sensitive for the detection of white matter lesions (WML), which occur even in normal ageing. Intrinsic WML should be separated from physiological changes in the ageing brain, such as periventricular caps and bands, and from dilated Virchow-Robin spaces. Genuine WML are best seen with T2-weighted sequences such as long TR dual-echo spin-echo or FLAIR (fluid-attenuated inversion recovery); the latter has the advantage of easily separating WML from CSF-like lesions. Abnormal T2 signal in MRI is not specific, and can accompany any change in tissue composition. In the work-up of WML in small vessel disease, magnetic resonance angiography can be used to rule out (concomitant) large vessel disease, and diffusion-weighted MRI to identify new ischaemic lesions (amidst pre-existing old WML). The differential diagnosis of WML includes hereditary leukodystrophies and acquired disorders. The leukodystrophies that can present in adult age include metachromatic leukodystrophy, globoid cell leukodystrophy, adrenomyeloneuropathy, mitochondrial disorders, vanishing white matter, and cerebrotendinous xanthomatosis. These metabolic disorders typically present with symmetrical abnormalities that can be very diffuse, often with involvement of brainstem and cerebellum. Only the mitochondrial disorders tend to be more asymmetric and frequently involve the grey matter preferentially. Among the acquired white matter disorders, hypoxic-ischaemic causes are by far the most prevalent and without further clinical clues there is no need to even consider the next most common disorder, i.e. multiple sclerosis (MS). Among the nonischaemic disorders, MS is far more common than vasculitis, infection, intoxication and trauma. While vasculitis can mimic small vessel disease, MS has distinctive features with preferential involvement of the subcortical U-fibres, the corpus callosum, temporal lobes and the brainstem/cerebellum. Spinal cord lesions are very common in MS, but do not occur in normal ageing nor in small vessel disease.

Young IR, Hall AS, Pallis CA, Legg NJ, Bydder GM, Steiner RE: Nuclear magnetic resonance imaging of the brain in multiple sclerosis. Lancet 1981;ii:1063–1066.
Zimmerman RD, Fleming CA, Lee BCP, Saint-Louis LA, Feck MD: Periventricular hyperintensity as seen by magnetic resonance: Prevalence and significance. AJNR 1986;7:13–20.
Barkovich AJ, Kjos BO, Jackson DE, Norman D: Normal maturation of neonatal and infant brain: MR imaging at 1.5 T. Radiology 1988;166:173–180.
McLaurin J, Yong VW: Oligodendrocytes and myelin. Neurol Clin 1995;13:23–49.
Kamman RL, Go KG, Muskiet FAJ, Stomp GP, van Dijk P, Berebdsen HJC: Proton spin relaxation studies of fatty tissue and cerebral white matter. Magn Reson Imaging 1984;2:211–220.
Koenig SH, Brown RD III, Spiller M, et al: Relaxometry of brain: Why white matter appears bright in MRI. Magn Reson Med 1990;14:482–490.
Thorpe JW, Halpin SF, MacManus DG, Barker GJ, Kendall BE, Miller DH: A comparison between fast and conventional spin-echo in the detection of multiple sclerosis lesions. Neuroradiology 1994;36:388–392.
Finelli DA, Hurst GC, Gullapali RP, Bellon EM: Improved contrast of enhancing brain lesions on postgadolinium, T1-weighted spin-echo images with use of magnetization transfer. Radiology 1994;190:553–559.
Rydberg JN, Hammond CA, Grimm RC, et al: Initial clinical experience in MR imaging of the brain with a fast fluid-attenuated inversion-recovery pulse sequences. Radiology 1994;193:173–180.
Junreis CA, Kanal E, Hirsch WL, Maryinez AJ, Moossy J: Normal perivascular spaces mimicking lacunar infarction: MR imaging. Radiology 1988;169:101–104.
Braffman BH, Zimmerman RA, Trojanowski JQ, Gonatas NK, Hickey WF, Schlaepfer WW: Brain MR: Pathologic correlation with gross and histopathology. 1. Lacunar infarction and Virchow-Robin spaces. AJR 1988;151:551–558.
Heier LA, Bauer CJ, Schwartz L, Zimmerman RD, Morgello S, Deck MDF: Large Virchow-Robin spaces: MR clinical correlation. AJNR 1989;10:929–936.
Zimmerman RD, Fleming CA, Lee BCP, Saint-Louis LA, Deck MDF: Periventricular hyperintensity as seen by magnetic resonance: Prevalence and significance. AJNR 1986;7:13–20.
Leifer D, Buonoanno FS, Richardson EP: Clinicopatholgic correlations of cranial magnetic resonance imaging of periventricular white matter. Neurology 1990;40:911–918.
Scheltens P, Barkhof F, Leys D, Wolters EC, Ravid R, Kamphorst W: Histopathologic correlates of white matter changes on MRI in Alzheimer’s disease and normal aging. Neurology 1995;45:883–888.
Van der Knaap MS, Kamphorst W, Barth PG, Kraaijeveld CL, Gut E, Valk J: Phenotypic variation in leukoencephalopathy with vanishing white matter. Neurology 1998;51:540–547.
Loes DJ, Peters C, Krivit W: Globoid cell leukodystrophy: Distinguishing early-onset from late-onset disease using a brain MR imaging scoring method. AJNR Am J Neuroradiol 1999;20:316–323.
Barkhof F, Verrips A, Wesseling P, van der Knaap MS, van Engelen BG, Gabreels FJ, Keyser A, Wevers RA, Valk J: Cerebrotendinous xanthomatosis: The spectrum of imaging findings and the correlation with neuropathologic findings. Radiology 2000;217:869–876.
Paty DW, Oger JJF, Kastrukoff LF, et al: Magnetic resonance imaging in the diagnosis of multiple sclerosis: A prospective study of comparison with clinical evaluation, evoked potential, oligoclonal banding, and CT. Neurology 1988;38:180–185.
Fazekas F, Offenbacher H, Fuchs S, et al: Criteria for an increased specificity of MRI interpretation in elderly subjects with suspected multiple sclerosis. Neurology 1988;38:1822–1825.
Barkhof F, Filippi M, Miller DH, Scheltens P, Campi A, Polman CH, Comi G, Ader HJ, Losseff N, Valk J: Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 1997;120:2059–2069.
Tan IL, van Schijndel RA, Pouwels PJ, van Walderveen MA, Reichenbach JR, Manoliu RA, Barkhof F: MR venography of multiple sclerosis. AJNR Am J Neuroradiol 2000;21:1039–1042.
Moody DM, Bell MA, Challa VR: The corpus callosum, a unique white matter tract: Anatomic features that may explain sparing in Binswanger’s disease and resistance to flow of fluid masses. AJNR 1988;9:1051–1059.
Auer DP, Putz B, Gossl C, Elbel G, Gasser T, Dichgans M: Differential lesion patterns in CADASIL and sporadic subcortical arteriosclerotic encephalopathy: MR imaging study with statistical parametric group comparison. Radiology 2001;218:443–451.
Lycklama à Nijeholt GJ, van Walderveen MA, Castelijns JA, van Waesberghe JH, Polman C, Scheltens P, Rosier PF, Jongen PJ, Barkhof F: Brain and spinal cord abnormalities in multiple sclerosis. Correlation between MRI parameters, clinical subtypes and symptoms. Brain 1998;121:687–697.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.